PE-Backed Biotech OptiNose Raises $120M In Upsized IPO
Private equity-backed medical device company OptiNose Inc. raised $120 million in an upsized initial public offering of 7.5 million shares that priced at $16 per share late Thursday and began trading...To view the full article, register now.
Already a subscriber? Click here to view full article